APOLLO HOSPITALS ENTER. L vs BAL PHARMA LTD.
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and BAL PHARMA LTD. (BALPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs BALPHARMA on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability40
- Growth20
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
BALPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company has been maintaining a healthy dividend payout of 27.5%"]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 4.46% over past five years.", "Tax rate seems low", "Company has a low return on equity of 9.37% over last 3 years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.